Skip to main content

Comet launches with $28M to turn Nobel Prize-winning science into drugs

The new Cambridge startup plans to revisit decades-old science in the hopes of treating diseases like multiple sclerosis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.